Schachen, Switzerland

Frank Bruno Guenter

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Frank Bruno Guenter: Innovator in Pharmaceutical Chemistry

Introduction

Frank Bruno Guenter is a notable inventor based in Schachen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of three patents to his name, Guenter's work is recognized for its innovative approach to drug formulation.

Latest Patents

Guenter's latest patents include the hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one. These patents disclose hydrochloride and tosylate crystalline salt forms of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I. The methods of preparing these compounds are also detailed in his patents, showcasing his expertise in this specialized area.

Career Highlights

Frank Bruno Guenter is currently employed at Opko Health, Inc., where he continues to advance his research and development efforts. His work at Opko Health has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Some of Guenter's notable coworkers include Mengwei Hu and Sunil Paliwal. Their collaborative efforts have played a crucial role in the successful development of new pharmaceutical compounds.

Conclusion

Frank Bruno Guenter is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…